Identification of CDK2 as a novel target in treatment of prostate cancer.

about

Identification of CDK2 as a novel target in treatment of prostate cancer.

Item

http://www.wikidata.org/entity/Q47738630

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Identification of CDK2 as a novel target in treatment of prostate cancer.

@en

Identification of CDK2 as a novel target in treatment of prostate cancer.

@nl

type

Item

label

Identification of CDK2 as a novel target in treatment of prostate cancer.

@en

Identification of CDK2 as a novel target in treatment of prostate cancer.

@nl

prefLabel

Identification of CDK2 as a novel target in treatment of prostate cancer.

@en

Identification of CDK2 as a novel target in treatment of prostate cancer.

@nl

P1476

Identification of CDK2 as a novel target in treatment of prostate cancer.

@en

P2093

Binghai Chen

http://www.w3.org/2001/XMLSchema#string

Chengyue Wang

http://www.w3.org/2001/XMLSchema#string

Hao Sun

http://www.w3.org/2001/XMLSchema#string

Jun Yu

http://www.w3.org/2001/XMLSchema#string

Xifeng Yin

http://www.w3.org/2001/XMLSchema#string

Yang Zhou

http://www.w3.org/2001/XMLSchema#string

Zhimin Jiao

http://www.w3.org/2001/XMLSchema#string

Zhounan Qian

http://www.w3.org/2001/XMLSchema#string

P2860

Cell cycle, CDKs and cancer: a changing paradigm

Cytoscape: a software environment for integrated models of biomolecular interaction networks

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

ERK-mediated NF-κB activation through ASIC1 in response to acidosis

STATs in cancer inflammation and immunity: a leading role for STAT3

STRING v10: protein-protein interaction networks, integrated over the tree of life

Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression

Androgen suppresses the proliferation of androgen receptor-positive castration-resistant prostate cancer cells via inhibition of Cdk2, CyclinA, and Skp2.

P31

scholarly article

P356

10.2217/FON-2017-0561

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2018-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29323532

http://www.w3.org/2001/XMLSchema#string